The Medical Letter on Drugs and Therapeutics

In two weeks, the publication nonprofit that provides assessment, unbiased and critical of the drug, with particular emphasis on new drugs, doctors and other health professionals.

cons The Medical Letter on Drugs and Therapeutics is an independent, peer-reviewed, published, non-profit that provides an objective assessment of critical drugs. With an emphasis on new drugs, doctors and other health professionals is reliable, up to the minute information from the ease and convenience of their handheld device. It evaluates virtually all new drugs and reviews older drugs when important, new prescribing information is available. The Medical Letter on Drugs and Therapeutics began publication in 1959 and is now part of everyday practice of many physicians, pharmacists, nurse practitioners, medical educators, residents and interns, and students in medicine and pharmacy. The Medical Letter is intended to meet the needs of healthcare busy professional who wants unbiased, reliable and timely information on new drugs. Many of these professionals are aware that manufacturers and their representatives in May overstated the therapeutic effects and underestimate the adverse effects of drugs, but have neither the time nor the means to verify the accuracy of fabricants''revendications. If a new drug offers real advantages over older drugs, The Medical Letter on Drugs and cons of therapeutic said. If it provides no benefit if its effectiveness is limited, or if it is too toxic or too expensive to justify its use, The Medical Letter on Drugs and cons of therapeutic said. If new information changes the picture, monitoring reports are published. Cons The Medical Letter on Drugs and Therapeutics is updated bi-weekly with the best information available drugs. Just sync your device automatically handheld and receive the latest edition of